Valeo Pharma Inc
TSX:VPH
Cash Flow Statement
Cash Flow Statement
Valeo Pharma Inc
Oct-2021 | Jan-2022 | Apr-2022 | Jul-2022 | Oct-2022 | Jan-2023 | Apr-2023 | Jul-2023 | Oct-2023 | Jan-2024 | ||
---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow | |||||||||||
Net Income |
(14)
|
(18)
|
(22)
|
(23)
|
(26)
|
(26)
|
(28)
|
(29)
|
(28)
|
(28)
|
|
Depreciation & Amortization |
1
|
0
|
1
|
1
|
1
|
2
|
2
|
3
|
3
|
3
|
|
Change in Deffered Taxes |
0
|
0
|
0
|
0
|
(1)
|
0
|
0
|
0
|
0
|
0
|
|
Other Non-Cash Items |
3
|
3
|
3
|
3
|
8
|
8
|
10
|
10
|
5
|
6
|
|
Cash Interest Paid |
0
|
0
|
0
|
0
|
3
|
0
|
0
|
0
|
7
|
0
|
|
Change in Working Capital |
(1)
|
(4)
|
(6)
|
(1)
|
(11)
|
(13)
|
(8)
|
(7)
|
4
|
17
|
|
Cash from Operating Activities |
(12)
N/A
|
(19)
-52%
|
(23)
-25%
|
(20)
+14%
|
(29)
-43%
|
(31)
-7%
|
(25)
+18%
|
(24)
+4%
|
(16)
+35%
|
(3)
+81%
|
|
Investing Cash Flow | |||||||||||
Capital Expenditures |
(3)
|
(4)
|
(2)
|
(13)
|
(7)
|
(7)
|
(7)
|
4
|
(6)
|
(5)
|
|
Other Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Cash from Investing Activities |
(3)
N/A
|
(4)
-1%
|
(2)
+55%
|
(13)
-732%
|
(7)
+47%
|
(7)
0%
|
(7)
-2%
|
4
N/A
|
(6)
N/A
|
(5)
+7%
|
|
Financing Cash Flow | |||||||||||
Net Issuance of Common Stock |
13
|
12
|
12
|
1
|
0
|
0
|
0
|
(0)
|
4
|
0
|
|
Net Issuance of Debt |
4
|
24
|
17
|
55
|
20
|
(1)
|
(1)
|
(38)
|
3
|
3
|
|
Other |
(2)
|
(3)
|
(3)
|
(4)
|
35
|
36
|
36
|
40
|
(0)
|
(0)
|
|
Cash from Financing Activities |
15
N/A
|
34
+123%
|
26
-22%
|
52
+96%
|
55
+6%
|
36
-35%
|
36
+1%
|
1
-97%
|
6
+465%
|
7
+8%
|
|
Change in Cash | |||||||||||
Effect of Foreign Exchange Rates |
(0)
|
(0)
|
0
|
(0)
|
1
|
1
|
1
|
1
|
0
|
0
|
|
Net Change in Cash |
(1)
N/A
|
11
N/A
|
2
-86%
|
19
+1 089%
|
20
+9%
|
(1)
N/A
|
5
N/A
|
(18)
N/A
|
(15)
+16%
|
(1)
+91%
|
|
Free Cash Flow | |||||||||||
Free Cash Flow |
(16)
N/A
|
(22)
-41%
|
(25)
-12%
|
(33)
-33%
|
(35)
-7%
|
(37)
-6%
|
(32)
+14%
|
(20)
+38%
|
(21)
-8%
|
(8)
+60%
|